Literature DB >> 33487119

Toll-like receptor 4 mediates blood-brain barrier permeability and disease in C3H mice during Venezuelan equine encephalitis virus infection.

Bradley S Hollidge1,2, Courtney A Cohen1, Justice Akuoku Frimpong1,3, Catherine V Badger1, John M Dye1, Connie S Schmaljohn4,5.   

Abstract

Venezuelan equine encephalitis virus (VEEV) is an encephalitic alphavirus that can cause debilitating, acute febrile illness and potentially result in encephalitis. Currently, there are no FDA-licensed vaccines or specific therapeutics for VEEV. Previous studies have demonstrated that VEEV infection results in increased blood-brain barrier (BBB) permeability that is mediated by matrix metalloproteinases (MMPs). Furthermore, after subarachnoid hemorrhage in mice, MMP-9 is upregulated in the brain and mediates BBB permeability in a toll-like receptor 4 (TLR4)-dependent manner. Here, we demonstrate that disease in C3H mice during VEEV TC-83 infection is dependent on TLR4 because intranasal infection of C3H/HeN (TLR4 WT ) mice with VEEV TC-83 resulted in mortality as opposed to survival of TLR4-defective C3H/HeJ (TLR4 mut ) mice. In addition, BBB permeability was induced to a lesser extent in TLR4 mut mice compared with TLR4 WT mice during VEEV TC-83 infection as determined by sodium fluorescein and fluorescently-conjugated dextran extravasation. Moreover, MMP-9, MMP-2, ICAM-1, CCL2 and IFN-γ were all induced to significantly lower levels in the brains of infected TLR4 mut mice compared with infected TLR4 WT mice despite the absence of significantly different viral titers or immune cell populations in the brains of infected TLR4 WT and TLR4 mut mice. These data demonstrate the critical role of TLR4 in mediating BBB permeability and disease in C3H mice during VEEV TC-83 infection, which suggests that TLR4 is a potential target for the development of therapeutics for VEEV.

Entities:  

Keywords:  Venezuelan equine encephalitis virus; blood-brain barrier; tlr4; toll-like receptor 4; veev

Year:  2021        PMID: 33487119      PMCID: PMC7849679          DOI: 10.1080/21505594.2020.1870834

Source DB:  PubMed          Journal:  Virulence        ISSN: 2150-5594            Impact factor:   5.882


  67 in total

1.  [Epidemiological studies on case of Venezuelan equine encephalomyelitis in a laboratory].

Authors:  A N SLEPUSHKIN
Journal:  Vopr Virusol       Date:  1959 May-Jun

2.  Chemokine CCL2 contributes to BBB disruption via the p38 MAPK signaling pathway following acute intracerebral hemorrhage.

Authors:  Fuyou Guo; Dingkang Xu; Yazhou Lin; Guoqing Wang; Fang Wang; Qiang Gao; Qingjie Wei; Shixiong Lei
Journal:  FASEB J       Date:  2019-12-10       Impact factor: 5.191

3.  Natural killer cell mediated pathogenesis determines outcome of central nervous system infection with Venezuelan equine encephalitis virus in C3H/HeN mice.

Authors:  Katherine Taylor; Olga Kolokoltsova; Michael Patterson; Allison Poussard; Jennifer Smith; D Mark Estes; Slobodan Paessler
Journal:  Vaccine       Date:  2012-04-21       Impact factor: 3.641

4.  Replicon particles of Venezuelan equine encephalitis virus as a reductionist murine model for encephalitis.

Authors:  Alexandra Schäfer; Alan C Whitmore; Jennifer L Konopka; Robert E Johnston
Journal:  J Virol       Date:  2009-02-18       Impact factor: 5.103

5.  Pivotal advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis.

Authors:  Asa Andersson; Ruxandra Covacu; Dan Sunnemark; Alexandre I Danilov; Assunta Dal Bianco; Mohsen Khademi; Erik Wallström; Anna Lobell; Lou Brundin; Hans Lassmann; Robert A Harris
Journal:  J Leukoc Biol       Date:  2008-07-21       Impact factor: 4.962

Review 6.  The Human Immune Response to Respiratory Syncytial Virus Infection.

Authors:  Clark D Russell; Stefan A Unger; Marc Walton; Jürgen Schwarze
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

7.  Shed GP of Ebola virus triggers immune activation and increased vascular permeability.

Authors:  Beatriz Escudero-Pérez; Valentina A Volchkova; Olga Dolnik; Philip Lawrence; Viktor E Volchkov
Journal:  PLoS Pathog       Date:  2014-11-20       Impact factor: 6.823

Review 8.  Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology.

Authors:  Rudragouda Channappanavar; Stanley Perlman
Journal:  Semin Immunopathol       Date:  2017-05-02       Impact factor: 9.623

9.  Novel strategies for targeting innate immune responses to influenza.

Authors:  K A Shirey; W Lai; M C Patel; L M Pletneva; C Pang; E Kurt-Jones; M Lipsky; T Roger; T Calandra; K J Tracey; Y Al-Abed; A G Bowie; A Fasano; C A Dinarello; F Gusovsky; J C G Blanco; S N Vogel
Journal:  Mucosal Immunol       Date:  2016-01-27       Impact factor: 7.313

10.  Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury.

Authors:  Yumiko Imai; Keiji Kuba; G Greg Neely; Rubina Yaghubian-Malhami; Thomas Perkmann; Geert van Loo; Maria Ermolaeva; Ruud Veldhuizen; Y H Connie Leung; Hongliang Wang; Haolin Liu; Yang Sun; Manolis Pasparakis; Manfred Kopf; Christin Mech; Sina Bavari; J S Malik Peiris; Arthur S Slutsky; Shizuo Akira; Malin Hultqvist; Rikard Holmdahl; John Nicholls; Chengyu Jiang; Christoph J Binder; Josef M Penninger
Journal:  Cell       Date:  2008-04-18       Impact factor: 41.582

View more
  2 in total

1.  Intrinsic antiviral immunity of barrier cells revealed by an iPSC-derived blood-brain barrier cellular model.

Authors:  Yichen Cheng; Angelica Medina; Zhenlan Yao; Mausumi Basu; Janhavi P Natekar; Jianshe Lang; Egan Sanchez; Mezindia B Nkembo; Chongchong Xu; Xuyu Qian; Phuong T T Nguyen; Zhexing Wen; Hongjun Song; Guo-Li Ming; Mukesh Kumar; Margo A Brinton; Melody M H Li; Hengli Tang
Journal:  Cell Rep       Date:  2022-05-31       Impact factor: 9.995

Review 2.  SARS-CoV-2: is there neuroinvasion?

Authors:  Conor McQuaid; Molly Brady; Rashid Deane
Journal:  Fluids Barriers CNS       Date:  2021-07-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.